XTX Topco’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$366K Buy
77,861
+29,870
+62% +$152K 0.01% 2305
2025
Q4
$204K Buy
47,991
+18,705
+64% +$71.1K 0.01% 2386
2025
Q3
$93.4K Sell
29,286
-92,613
-76% -$209K ﹤0.01% 2036
2025
Q2
$277K Buy
+121,899
New +$196K 0.01% 1492
2025
Q1
Sell
-32,922
Closed -$33.9K 2528
2024
Q4
$33.9K Sell
32,922
-10,742
-25% -$11.6K ﹤0.01% 1962
2024
Q3
$51.5K Sell
43,664
-16,922
-28% -$21.5K ﹤0.01% 1690
2024
Q2
$73.9K Buy
60,586
+48,033
+383% +$95.6K 0.01% 1458
2024
Q1
$27.4K Sell
12,553
-7,720
-38% -$14.2K ﹤0.01% 1571
2023
Q4
$31.4K Buy
+20,273
New +$26.7K 0.01% 1300
2023
Q2
Sell
-17,815
Closed -$26.9K 1482
2023
Q1
$26.9K Sell
17,815
-11,762
-40% -$26.6K 0.01% 1201
2022
Q4
$47.3K Sell
29,577
-15,271
-34% -$22.6K 0.01% 1046
2022
Q3
$65K Sell
44,848
-55,756
-55% -$85.8K 0.02% 1002
2022
Q2
$184K Sell
100,604
-17,735
-15% -$34K 0.08% 486
2022
Q1
$316K Buy
118,339
+108,174
+1,064% +$415K 0.14% 250
2021
Q4
$44K Buy
+10,165
New +$59.5K 0.02% 578
2021
Q3
Sell
-21,422
Closed -$136K 748
2021
Q2
$136K Buy
+21,422
New +$167K 0.05% 623

Other funds holding CTMX